Should population-based CVD risk assessment models make way for individualised risk prediction techniques?
Cardiovascular disease (CVD) is a leading cause of death worldwide and a major contributor to reduced quality of life. Clinical decision making for the detection, management and prevention of CVD relies on accurate risk assessment. Local and international guidelines currently advocate for measurement of traditional CVD risk factors with use of a validated risk prediction tool. However, the realisation that traditional risk factors may not identify all those at risk of CVD has fueled a growing interest in the use of novel imaging techniques, clinical biomarkers and genetics to augment traditional risk assessment.
To celebrate World Heart Day, the Heart Foundation of Australia and World Heart Federation invites you to join us for a global clinical debate on the future of CVD risk assessment.
This webinar will be chaired by Prof Garry Jennings, Chief Medical Advisor, Heart Foundation of Australia.